Morning Briefing
Summaries of health policy coverage from major news organizations
FDA To Review Birth Control Implant Safety
The Associated Press: FDA Experts To Review Safety Of Essure Birth Control Implant
Federal medical experts will take a closer look at a host of problems reported with the birth control implant called Essure, including chronic pain, bleeding, headaches and allergic reactions. Essure has been sold for 13 years but the Food and Drug Administration has recently received a flurry of complaints from women implanted with the device, which is marketed as the only permanent birth control method that doesn't require surgery. (9/21)
The Wall Street Journal: Down Syndrome Blood Test Sparks Abortion Debate
A blood test that can predict if a fetus will have Down syndrome is growing in popularity. But since it can lead some couples to end pregnancies, it is sparking a debate. Disability rights’ advocates, researchers and clinicians note that people are now living longer, healthier and more productive lives with Down syndrome, a genetic condition that causes intellectual disability, developmental delays and certain medical problems. (Marcus, 9/21)
